Yihui Lin - PharmaEngine Director
| 4162 Stock | TWD 90.70 0.50 0.55% |
Director
Yihui Lin is Director of PharmaEngine since 2018.
| Tenure | 6 years |
| Phone | 886 2 2515 8228 |
| Web | https://www.pharmaengine.com |
PharmaEngine Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Cindy Chu | Adimmune Corp | N/A | |
| Zhengyu Cheng | EirGenix | N/A | |
| Davis Liu | TaiMed Biologics | N/A | |
| Yida Lu | EirGenix | N/A | |
| Jianxin Zheng | Adimmune Corp | N/A | |
| LeeCheng Liu | EirGenix | N/A | |
| YunPeng Chu | Adimmune Corp | N/A | |
| Jiazhen Zhu | Adimmune Corp | N/A | |
| ChingChow Chen | TaiMed Biologics | N/A | |
| Liangjie Huang | EirGenix | N/A | |
| Yushu Lin | Adimmune Corp | N/A | |
| Meixiang He | Adimmune Corp | N/A | |
| Howard Lee | TaiMed Biologics | N/A | |
| Shitong Ding | Adimmune Corp | N/A | |
| Jiheng Lin | Adimmune Corp | N/A | |
| Zhaolian Huang | TaiMed Biologics | N/A | |
| Jingzhe Lin | EirGenix | N/A | |
| Jicheng Liao | Adimmune Corp | N/A | |
| Longye Zhuo | TaiMed Biologics | N/A | |
| MingChing Chen | TaiMed Biologics | N/A | |
| Shihua Xu | Oneness Biotech Co | N/A | |
Management Performance
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 |
PharmaEngine Leadership Team
Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiuji Zhang, Director | ||
| Lin C, Director | ||
| PoWu Gean, Director | ||
| Changjing Ye, CEO, General Manager, Director | ||
| HongRen Wang, Pres CEO | ||
| Yusheng Zhao, Director | ||
| LiSheng Chu, Independent Director | ||
| Fuxiu Yin, Independent Director | ||
| Guocai Pan, Director | ||
| Yuqing Su, Independent Director | ||
| ChiHsing Chang, VP Devel | ||
| Kunhong Lai, Independent Director | ||
| Chuan Lin, Director | ||
| YuFang Hu, General Manager | ||
| Bowu Jian, Director | ||
| Qiying Huang, Director | ||
| Jinrong Lin, Director | ||
| Jeffrey Suen, Chairman of the Board | ||
| Peter Wu, Director Sales | ||
| Junhui He, Chairman of the Board | ||
| Quan Lin, Director | ||
| Zhili Wang, Independent Director | ||
| C Chang, Deputy General Manager-Finance & Administration | ||
| Kangji Zhou, Independent Director | ||
| Hubert Chan, Deputy General Manager-Clinical & Regulatory Affairs | ||
| KangChi Chou, Independent Director | ||
| Melody Lin, Director HR | ||
| Lizhen Lin, Director | ||
| Li Lin, Director | ||
| Qixing Zhang, Senior Head-Finance and Administration Management | ||
| WenHwa Chang, Director | ||
| Ruiwen Wu, Director | ||
| Yihui Lin, Director | ||
| Jose Hsieh, Sr Accounting | ||
| Zhaosheng Wu, Deputy Head of Development Department | ||
| FuShiow Yin, Independent Director | ||
| Huai Wang, Independent Director | ||
| Grace Yeh, CEO, General Manager, Director | ||
| Qixiang Chen, Director | ||
| MingThau Sheu, Director | ||
| Xinyi Lin, Director |
PharmaEngine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.53 % | |||
| Current Valuation | 14.42 B | |||
| Shares Outstanding | 143.69 M | |||
| Shares Owned By Insiders | 22.57 % | |||
| Shares Owned By Institutions | 20.72 % | |||
| Price To Book | 4.72 X | |||
| Price To Sales | 24.13 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for PharmaEngine Stock analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |